Abstract
The objectives of the study were to review current literature and to present own data concerning etiology, clinical features and management of patients with childhood-onset growth hormone (GH) deficiency that continues into adulthood. Special attention was paid to the effects of GH-replacement therapy on metabolic and cardiac parameters. GH-replacement seems to reduce cardiovascular risks in young adults with childhood-onset GH-deficiency. Data from recent studies suggest that, due to severe consequences of GH- deficiency, patients need GH-therapy to be resumed or continued in transition period from adolescence to adult life (after reassessment of GH-status).
Downloads
Download data is not yet available.